Do pay-for-performance schemes improve quality in community pharmacy? A mixed-methods study exploring stakeholder perspectives on implementation of the nationwide Pharmacy Quality Scheme (PQS) in England?

被引:0
作者
Schafheutle, Ellen Ingrid [1 ]
Moss, Aidan Akira [2 ]
Hindi, Ali Mawfek Khaled [1 ]
Gibson, Jon [3 ]
Lovatt, Emma [2 ]
Robinson, Katie [2 ]
Jacobs, Sally [1 ]
机构
[1] Univ Manchester, Sch Hlth Sci, Ctr Pharm Workforce Studies, Fac Biol Med & Hlth, Manchester, England
[2] ICF Res & Evaluat Consulting Serv, London, England
[3] Univ Manchester, Sch Hlth Sci, Fac Biol Med & Hlth, Div Populat Hlth Hlth Serv Res & Primary Care, Manchester, England
关键词
FRAMEWORK; OUTCOMES; INCENTIVES;
D O I
10.1371/journal.pone.0319215
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Main study objectives To evaluate implementation and impact (at pharmacy and system level) of the pharmacy quality scheme (PQS), a pay-for-performance quality incentive scheme in community pharmacies in England since 2017.Methods Mixed-methods evaluation. Three linked datasets for 2021/22 (n = 10,135) were analysed for impact of pharmacy size, type (independent, chain, supermarket), location, prescription volume, and region on PQS participation, domains completion and payments. Forty-one qualitative interviews conducted with pharmacists, employers and representative bodies explored views and experiences of PQS implementation and impact. Harrington et al.'s conceptual framework for evaluating community pharmacy pay-for-performance programmes guided qualitative data analysis.Results Nearly all community pharmacies in England participated in PQS, with differences identified between chains (99% participation) and independents (16.5%), with income via PQS being an important motivator. Interviewees agreed with policy-makers about the purpose of the PQS being patient safety, patient experience, and clinical effectiveness. Beyond these core dimensions, consistency of service provision, sustainability, and wider system integration were considered important. While PQS was largely viewed as positively impacting pharmacy teams, clinical practice, and patient care, interviewees felt that increasing workloads across the sector made it challenging to focus on quality. They felt that there was a lack of feedback, that impacts were not always visible, and indeed frontline pharmacists were often not aware of published evidence of PQS impacts. Multiple sources of guidance lead to duplication and confusion. Particularly independent pharmacies found PQS workload burdensome and complex.Conclusion The primary incentive for PQS engagement revolved around income stability for employers, with some positive impact achieved, but obstacles concerning resource implications and sustainability persist. Considering concerns about the viability of community pharmacy and the importance of increasing the scope of pharmaceutical services, these implementation challenges should lead policy-makers to question how best to incentivise quality.
引用
收藏
页数:19
相关论文
共 27 条
[1]  
[Anonymous], 2024, Pharmacy quality scheme-Audit reports
[2]  
[Anonymous], 2014, NHS 5 YEAR FORWARD V
[3]  
[Anonymous], 2019, Community pharmacy NSAID safety audit 2018-19. Gastroprotection in people aged 65 years and above. Quality payments scheme (February 2019 review point) interim report
[4]   Determinants of the uptake of medicines use reviews (MURs) by community pharmacies in England: A multi-method study [J].
Bradley, Fay ;
Wagner, Andrew C. ;
Elvey, Rebecca ;
Noyce, Peter R. ;
Ashcroft, Darren M. .
HEALTH POLICY, 2008, 88 (2-3) :258-268
[5]  
Community Pharmacy Quality Scheme, 2022, 2019/20 Valproate audit report
[6]  
Department of Health, 2008, High quality care for all: NHS next stage review final report
[7]  
Doucette WR, 2021, J MANAG CARE SPEC PH, V27, P1198, DOI 10.18553/jmcp.2021.27.9.1198
[8]   Effects of pay for performance in health care: A systematic review of systematic reviews [J].
Eijkenaar, Frank ;
Emmert, Martin ;
Scheppach, Manfred ;
Schoeffski, Oliver .
HEALTH POLICY, 2013, 110 (2-3) :115-130
[9]   Key issues in the design of pay for performance programs [J].
Eijkenaar, Frank .
EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2013, 14 (01) :117-131
[10]   The role of the Quality and Outcomes Framework in the care of long-term conditions: a systematic review [J].
Forbes, Lindsay J. L. ;
Marchand, Catherine ;
Doran, Tim ;
Peckham, Stephen .
BRITISH JOURNAL OF GENERAL PRACTICE, 2017, 67 (664) :E775-E784